Connect with us
Gilead is acquiring German biotech firm Tubulis for up to $5 billion, benefiting Evotec, which holds a 3.14 percent stake and expects about $100 million upfront...
Evotec SE remains in focus after a turbulent year marked by a profit warning, cyberattack, and leadership change. The Hamburg-based biotech partner works with firms like...
BioNTech saw a sharp drop in profits, starting 2024 with a €315 million loss, down from a €502 million profit the previous year, and sales plummeting...